ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.122,25
0,95%
S&P 500
5.064,20
0,91%
US Dollar vs BRL
5,1109
-0,02%
Bitcoin
59.359,19
0,40%
Brent Oil
83,81
0,22%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Bio Rad Laboratories Inc (BIO.B)

  7. Bio Rad Laboratories Inc (BIO.B) Notícias

BIO.B

Bio Rad Laboratories (BIO.B)

Bio Rad Laboratories Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:BIO.B
DataHoraFonteTítuloCódigoCompanhia
18/04/202410:00Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NYSE:BIO.BBio Rad Laboratories Inc
10/04/202417:15Business WireBio-Rad’s Chief Operating Officer Andrew Last to RetireNYSE:BIO.BBio Rad Laboratories Inc
11/03/202410:59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BIO.BBio Rad Laboratories Inc
29/02/202419:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
28/02/202420:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIO.BBio Rad Laboratories Inc
21/02/202418:31Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIO.BBio Rad Laboratories Inc
16/02/202418:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:BIO.BBio Rad Laboratories Inc
15/02/202418:15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:BIO.BBio Rad Laboratories Inc
27/10/202317:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIO.BBio Rad Laboratories Inc
27/09/202317:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:BIO.BBio Rad Laboratories Inc
15/06/202318:13Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:BIO.BBio Rad Laboratories Inc
07/06/202312:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BIO.BBio Rad Laboratories Inc
05/06/202309:46Edgar (US Regulatory)Current Report Filing (8-k)NYSE:BIO.BBio Rad Laboratories Inc
24/05/202317:51Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:BIO.BBio Rad Laboratories Inc
05/05/202317:32Edgar (US Regulatory)Quarterly Report (10-q)NYSE:BIO.BBio Rad Laboratories Inc
29/03/202317:37Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:BIO.BBio Rad Laboratories Inc
29/03/202317:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:BIO.BBio Rad Laboratories Inc
09/02/202313:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:BIO.BBio Rad Laboratories Inc
08/02/202310:00PR Newswire (US)Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep KitsNYSE:BIO.BBio Rad Laboratories Inc
06/05/202213:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:BIO.BBio Rad Laboratories Inc
11/04/202217:46Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:BIO.BBio Rad Laboratories Inc
25/02/202209:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NYSE:BIO.BBio Rad Laboratories Inc
24/02/202208:08Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:BIO.BBio Rad Laboratories Inc
23/02/202210:40Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:BIO.BBio Rad Laboratories Inc
08/02/202112:19Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:BIO.BBio Rad Laboratories Inc
21/12/202013:09Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:BIO.BBio Rad Laboratories Inc
02/03/202009:55Edgar (US Regulatory)Annual Report (10-k)NYSE:BIO.BBio Rad Laboratories Inc
27/08/201918:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:BIO.BBio Rad Laboratories Inc
04/03/201909:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NYSE:BIO.BBio Rad Laboratories Inc
26/04/201817:47Edgar (US Regulatory)Amended Annual Report (10-k/a)NYSE:BIO.BBio Rad Laboratories Inc
 Apresentando as notícias mais relevantes sobre:NYSE:BIO.B

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BBDC4
BRADESCO PN
BOV
PRIO3
PETRORIO ON
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
BEES3
BANESTES ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados